Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced the grant and/or allowance of a series of patents and patent applications. These patents and patent applications, which were granted/allowed in 2020 and 2021, are expected to provide broad protection for Brainstorm’s proprietary NurOwn® (MSC-NTF cells) technology in territories including the U.S., E.U., Canada, Israel and Hong Kong.
Sunday’s Other Bowl Game: Inside Discovery’s Puppy Bowl XVIII
While millions of households will be tuned in on Sunday to watch the Los Angeles Rams take on the Cincinnati Bengals in Super Bowl LVI, other households will be viewing Team Ruff battling Team Fluff in the day’s other annual event, Puppy Bowl XVIII, on Discovery Communications Inc.’s
